U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Ovarian mucinous adenofibroma

MedGen UID:
309511
•Concept ID:
C1518723
•
Neoplastic Process
Synonyms: mucinous adenofibroma of ovary; Ovarian Mucinous Adenofibroma; ovarian mucinous adenofibroma; ovary mucinous adenofibroma
 
Monarch Initiative: MONDO:0003887

Definition

A benign neoplasm of the ovary characterized by the presence of glands with mucinous columnar epithelial cells in a fibrotic stroma. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVOvarian mucinous adenofibroma

Professional guidelines

PubMed

Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Results of treatment of primary ovarian carcinoma.
Saarikoski S, Selander K, Kauppila O, Raitala R, Pystynen P
Ann Chir Gynaecol 1982;71(3):156-60. PMID: 7114781

Recent clinical studies

Etiology

TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A, Schmeil I, Karn T, Becker S, Sänger N, Holtrich U, Arsenic R
Pathol Oncol Res 2018 Apr;24(2):277-282. Epub 2017 May 3 doi: 10.1007/s12253-017-0240-4. PMID: 28470574
Eosinophilic Cells, Autoimplants, Degree of Cellular Proliferation, and Adenofibroma Pattern are Important Histologic Findings in Ovarian Borderline Tumors.
Karpathiou G, Venet M, Chauleur C, Honeyman F, Casteillo F, Peoc'h M
Int J Gynecol Pathol 2017 Sep;36(5):447-452. doi: 10.1097/PGP.0000000000000361. PMID: 28796659
Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
Bartosch C, Pires-Luís AS, Meireles C, Baptista M, Gouveia A, Pinto C, Shannon KM, Jerónimo C, Teixeira MR, Lopes JM, Oliva E
Am J Surg Pathol 2016 Sep;40(9):1177-91. doi: 10.1097/PAS.0000000000000684. PMID: 27340747
Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M, Haouy D, Daraï E, Cortez A, Dechoux-Vodovar S, Thomassin-Naggara I
Clin Radiol 2013 Jan;68(1):e1-8. Epub 2012 Oct 6 doi: 10.1016/j.crad.2012.08.021. PMID: 23044365
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article

Diagnosis

Multimodality Imaging Approach to Ovarian Neoplasms with Pathologic Correlation.
Taylor EC, Irshaid L, Mathur M
Radiographics 2021 Jan-Feb;41(1):289-315. Epub 2020 Nov 13 doi: 10.1148/rg.2021200086. PMID: 33186060
Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation.
Marko J, Marko KI, Pachigolla SL, Crothers BA, Mattu R, Wolfman DJ
Radiographics 2019 Jul-Aug;39(4):982-997. doi: 10.1148/rg.2019180221. PMID: 31283462Free PMC Article
Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M, Haouy D, Daraï E, Cortez A, Dechoux-Vodovar S, Thomassin-Naggara I
Clin Radiol 2013 Jan;68(1):e1-8. Epub 2012 Oct 6 doi: 10.1016/j.crad.2012.08.021. PMID: 23044365
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
Prat J
Mod Pathol 2005 Feb;18 Suppl 2:S99-111. doi: 10.1038/modpathol.3800312. PMID: 15492758

Therapy

Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index.
O'Hanlan KA, Huang GS, Lopez L, Garnier AC
Gynecol Oncol 2004 Apr;93(1):137-43. doi: 10.1016/j.ygyno.2003.12.020. PMID: 15047227
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Rose PG, Faulhaber P, Miraldi F, Abdul-Karim FW
Gynecol Oncol 2001 Jul;82(1):17-21. doi: 10.1006/gyno.2001.6246. PMID: 11426956

Prognosis

Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation.
Marko J, Marko KI, Pachigolla SL, Crothers BA, Mattu R, Wolfman DJ
Radiographics 2019 Jul-Aug;39(4):982-997. doi: 10.1148/rg.2019180221. PMID: 31283462Free PMC Article
TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A, Schmeil I, Karn T, Becker S, Sänger N, Holtrich U, Arsenic R
Pathol Oncol Res 2018 Apr;24(2):277-282. Epub 2017 May 3 doi: 10.1007/s12253-017-0240-4. PMID: 28470574
Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M, Haouy D, Daraï E, Cortez A, Dechoux-Vodovar S, Thomassin-Naggara I
Clin Radiol 2013 Jan;68(1):e1-8. Epub 2012 Oct 6 doi: 10.1016/j.crad.2012.08.021. PMID: 23044365
Clear cell carcinoma of the ovary: is there a role of histology-specific treatment?
Takano M, Tsuda H, Sugiyama T
J Exp Clin Cancer Res 2012 Jun 1;31(1):53. doi: 10.1186/1756-9966-31-53. PMID: 22655678Free PMC Article
Ovarian carcinomas, including secondary tumors: diagnostically challenging areas.
Prat J
Mod Pathol 2005 Feb;18 Suppl 2:S99-111. doi: 10.1038/modpathol.3800312. PMID: 15492758

Clinical prediction guides

TFF3 Expression as Stratification Marker in Borderline Epithelial Tumors of the Ovary.
El-Balat A, Schmeil I, Karn T, Becker S, Sänger N, Holtrich U, Arsenic R
Pathol Oncol Res 2018 Apr;24(2):277-282. Epub 2017 May 3 doi: 10.1007/s12253-017-0240-4. PMID: 28470574
Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
Bartosch C, Pires-Luís AS, Meireles C, Baptista M, Gouveia A, Pinto C, Shannon KM, Jerónimo C, Teixeira MR, Lopes JM, Oliva E
Am J Surg Pathol 2016 Sep;40(9):1177-91. doi: 10.1097/PAS.0000000000000684. PMID: 27340747
Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
Kotowicz B, Fuksiewicz M, Sobiczewski P, Spiewankiewicz B, Jonska-Gmyrek J, Skrzypczak M, Kowalska M
Eur J Obstet Gynecol Reprod Biol 2015 Nov;194:141-6. Epub 2015 Sep 12 doi: 10.1016/j.ejogrb.2015.09.008. PMID: 26398337
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Yamashita Y, Nagasaka T, Naiki-Ito A, Sato S, Suzuki S, Toyokuni S, Ito M, Takahashi S
Mod Pathol 2015 Jan;28(1):111-7. Epub 2014 Apr 11 doi: 10.1038/modpathol.2014.61. PMID: 24721826
Is MRI a useful tool to distinguish between serous and mucinous borderline ovarian tumours?
Bazot M, Haouy D, Daraï E, Cortez A, Dechoux-Vodovar S, Thomassin-Naggara I
Clin Radiol 2013 Jan;68(1):e1-8. Epub 2012 Oct 6 doi: 10.1016/j.crad.2012.08.021. PMID: 23044365

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...